World's Best Scientists 2026 revealed!
William J. Gradishar

William J. Gradishar

D-Index & Metrics

Biology and Biochemistry

D-Index
80
Citations
31240
World Ranking
4006
National Ranking
1977

Medicine

D-Index
84
Citations
37179
World Ranking
14865
National Ranking
7516

Overview

William J. Gradishar is affiliated with Northwestern University in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging, and Molecular Biology.

The scientist's work includes numerous publications on advanced cancer therapies and diagnostics. Key research topics include Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Cancer Cells and Metastasis, and Monoclonal and Polyclonal Antibodies Research.

Frequent co-authors collaborating with William J. Gradishar include:

  • Massimo Cristofanilli
  • Lorenzo Gerratana
  • Andrew A. Davis
  • Ami N. Shah
  • Amir Behdad

They have published extensively in several scientific journals. Frequent publication venues are:

  • Cancer Research
  • Journal of Clinical Oncology
  • Journal Watch
  • ONCOLOGY
  • Clinical Cancer Research

Among the recent papers authored by William J. Gradishar are:

  • Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology (2020), Journal of the National Comprehensive Cancer Network
  • Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology (2022), Journal of the National Comprehensive Cancer Network
  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 (2021), Annals of Oncology
  • Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial (2020), Journal of Clinical Oncology
  • Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium (2020), Breast Cancer Research and Treatment

William J. Gradishar's work contributes to multiple aspects of cancer research, with a significant emphasis on breast cancer treatments and clinical guidelines. Their research outputs have been influential within the oncology research community, as indicated by citation metrics of key publications.

Best Publications

  • Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

    William J. Gradishar;Sergei Tjulandin;Neville Davidson;Heather Shaw

  • Clinical practice guidelines in oncology

    William J. Gradishar;Benjamin O. Anderson;Ron Balassanian;Sarah L. Blair

  • Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

    Marc L. Citron;Donald A. Berry;Constance Cirrincione;Clifford Hudis

  • Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

    Jeffrey Crawford;Howard Ozer;Ronald Stoller;David H Johnson

  • Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    William J. Gradishar;Benjamin O. Anderson;Jame Abraham;Rebecca Aft

  • Albumin-bound paclitaxel: a next-generation taxane

    William J Gradishar

  • Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.

    Stephen Chia;William Gradishar;Louis Mauriac;Jose Bines

  • American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants

    Martee L. Hensley;Karen L. Hagerty;Tarun Kewalramani;Daniel M. Green

  • Breast cancer: Clinical practice guidelines in oncology

    Robert W. Carlson;Benjamin O. Anderson;Harold J. Burstein;Charles E. Cox

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.

    H J Burstein;G Curigliano;B Thürlimann;W P Weber

  • NCCN Guidelines® insights breast cancer, version 1.2017: Featured updates to the NCCN Guidelines

    William J. Gradishar;Benjamin O. Anderson;Ron Balassanian;Sarah L. Blair

  • American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.

    Martee L. Hensley;Lynn M. Schuchter;Celeste Lindley;Neal J. Meropol

  • Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With >= 2 HER2-Directed Regimens: Phase III NALA Trial

    Cristina Saura;Mafalda Oliveira;Yin-Hsun Feng;Ming-Shen Dai

  • Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer

    Tiffany T.A. Traina;Tiffany T.A. Traina;Kathy Miller;Denise Yardley;Janice Eakle

  • Significantly Longer Progression-Free Survival With nab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer

    William J. Gradishar;Dimitry Krasnojon;Sergey Cheporov;Anatoly N. Makhson

  • Burnout and Career Satisfaction Among US Oncologists

    Tait D. Shanafelt;William J. Gradishar;Michael Kosty;Daniel Satele

  • Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.

    Ricardo L. B. Costa;Hyo Sook Han;William J. Gradishar

  • Invasive breast cancer version 1.2016

    William J. Gradishar;Benjamin O. Anderson;Ron Balassanian;Sarah L. Blair

  • Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.

    Jill R. Dietz;Meena S. Moran;Meena S. Moran;Steven J. Isakoff;Steven J. Isakoff;Scott H. Kurtzman

  • Randomized Phase III Trial of Marimastat Versus Placebo in Patients With Metastatic Breast Cancer Who Have Responding or Stable Disease After First-Line Chemotherapy: Eastern Cooperative Oncology Group Trial E2196

    Joseph A. Sparano;Patricia Bernardo;Patricia Stephenson;William J. Gradishar

Frequent Co-Authors

Massimo Cristofanilli
Massimo Cristofanilli Cornell University
Leonidas C. Platanias
Leonidas C. Platanias Northwestern University
Andrew M. Davis
Andrew M. Davis University of Chicago
Alfred W. Rademaker
Alfred W. Rademaker Northwestern University
Clifford A. Hudis
Clifford A. Hudis Memorial Sloan Kettering Cancer Center
Al B. Benson
Al B. Benson Northwestern University
Fatima Cardoso
Fatima Cardoso Champalimaud Foundation
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
George Somlo
George Somlo City Of Hope National Medical Center
Harold J. Burstein
Harold J. Burstein Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The rise of accredited online programs has opened new doors for students interested in biology and biochemistry. Flexible study options allow you to fit your education around work and personal commitments, while still receiving high-quality instruction. For those looking to accelerate their education, consider exploring online biology programs that help you earn your degree faster and move quickly into the workforce or graduate school.

Many biology students are interested in healthcare careers. An online asn program is a great pathway into nursing, blending core scientific knowledge with practical clinical skills. Alternatively, nutritional science is a growing field with strong career prospects—there are excellent opportunities through an online bachelor's in nutrition.

For those aiming for leadership roles in healthcare, a graduate degree such as a Master of Health Administration from top cahme accredited mha programs can provide an edge in management and administration. These online degrees offer flexible and innovative pathways to launch or advance your career in the life sciences.

Best Scientists Citing William J. Gradishar

Trending Scientists

Recently Published Articles